Financial statements Olimp Laboratories
Balance sheet data of OLIMP LABORATORIES
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 391 520 489,59 | 440 538 976,97 | 525 311 361,51 | 659 463 555,06 | 811 926 022,56 |
| A. Fixed assets | 214 895 658,82 | 245 686 437,23 | 325 588 728,84 | 418 136 284,93 | 489 418 837,95 |
| B. Current assets | 176 624 830,77 | 194 852 539,74 | 199 722 632,67 | 241 327 270,13 | 322 507 184,61 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 391 520 486,59 | 440 538 976,97 | 525 311 361,51 | 659 463 555,06 | 811 926 022,56 |
| A. Equity | 232 115 794,06 | 252 446 031,93 | 294 471 936,13 | 315 540 228,08 | 329 799 374,97 |
| B. Liabilities and provisions for liabilities | 159 404 692,53 | 188 092 945,04 | 230 839 425,38 | 343 923 326,98 | 482 126 647,59 |
| I. Long-term liabilities | 34 358 388,80 | 42 834 311,42 | 75 106 956,06 | 116 490 105,26 | 167 854 534,46 |
| II. Short-term liabilities | 82 570 960,49 | 96 696 562,44 | 88 646 556,54 | 134 911 201,33 | 212 058 310,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.